Personalized cancer therapy using a patient-derived tumor tissue xenograft model: a translational field worthy of exploring further?

Author： Jin Ketao He Kuifeng Li Guangliang Teng Lisong

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.7, Iss.5, 2010-09, pp. : 597-606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumor effect of FP3 in combination with cetuximab on patient-derived tumor tissue xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases

International Journal of Molecular Medicine, Vol. 30, Iss. 1, 2012-01 ,pp. : 126-132

Spandidos Publications

Access to resources Recommend Favorite

Patient‐derived organoid models help define personalized management of gastrointestinal cancer

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 2, 2018-01 ,pp. : e48-e60

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potent antitumor activity of cabozantinib, a c‐MET and VEGFR2 inhibitor, in a colorectal cancer patient‐derived tumor explant model

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 8, 2015-04 ,pp. : 1967-1975

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generation of pediatric liver cancer patient–derived xenograft platforms for pediatric liver cancer: A critical stage in the development of anticancer treatments

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1017-1019

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1121-1135

John Wiley & Sons Inc

Access to resources Recommend Favorite